ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Atlas Showing County Cancer Rates Available

July 18, 1975

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007

Obama’s First Budget Proposes $6 Billion For Cancer Research As Step To Doubling

February 27, 2009

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014